Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
563K
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
189K
-
Shares change
-
-53.3K
-
Total reported value, excl. options
-
$146K
-
Value change
-
-$68.7K
-
Number of buys
-
4
-
Number of sells
-
-6
-
Price
-
$0.77
Significant Holders of Bluejay Diagnostics, Inc. - Common Stock (BJDX) as of Q3 2022
12 filings reported holding BJDX - Bluejay Diagnostics, Inc. - Common Stock as of Q3 2022.
Bluejay Diagnostics, Inc. - Common Stock (BJDX) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 189K shares
of 563K outstanding shares and own 33.64% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (49.6K shares), GEODE CAPITAL MANAGEMENT, LLC (30.2K shares), SABBY MANAGEMENT, LLC (26.1K shares), VANGUARD GROUP INC (15.9K shares), MILLENNIUM MANAGEMENT LLC (15.9K shares), Verition Fund Management LLC (15K shares), UBS Group AG (13.4K shares), NORTHERN TRUST CORP (11.7K shares), Tower Research Capital LLC (TRC) (11.6K shares), and CITADEL ADVISORS LLC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.